Biogen stock touches 52-week low at $144.96 amid challenges By Investing.com
Biogen Idec Inc (NASDAQ:)’s stock has faced significant headwinds, touching a 52-week low of $144.96. The biotechnology firm, known for its innovative therapies for neurological diseases…





